Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/0f8c1721-ffca-4d82-b532-1d979620b605/
VLS
Vita Life Sciences LimitedSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
10 of 23 passing
★
OS Composite
OS 0.980
↗
Trending Value
#11.00000000
◆
Quality × Value
QV 0.955
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 10.00000000
📐
EBITDA/EV
14.5%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
Rev +17%
🔄
Shareholder Yield
5.9%
💰
High Yield
Div 4.3%
🚀
Momentum Leaders
12-1 27%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 93th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
93.0%ile
P/E
13.6×
P/S
1.5×
P/B
2.5×
E/P
0.1292
FCF Yield
0.146
EBITDA/EV
0.145
SH Yield
0.059
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
12.00000000
/100 — 1=cheapest
VC2 (Trending Value)
10.00000000
/100
VC3 (Buyback)
11.00000000
/100
FCF yield of 14.6% is strong — the business generates significant free cash relative to price. VC2 score of 10.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.186
ROA
0.127
Net Margin
0.112
Op Margin
0.151
GPA
0.693
Current
2.72
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.173
Earn Growth
0.211
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
91.0%ile
6M Return
10.8%
12M Return
35.3%
12-1 Mom
27.4%
Risk-Adj
0.73
Vol 252d
37.3%
Vol 60d
87.5%
↑ Expanding
Max DD 12M
-19.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 27% is very strong — a clear uptrend. Near-term vol (87%) is expanding vs long-term (37%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.98
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
95.9%
Sector Quality %ile
99.3%
P/E z-score
-0.43
P/B z-score
-0.35
Sector Avg OS
44.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (93th) and quality (98th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Trending Value Signal
Cheap (93th value) with strong momentum (91th). The market is starting to recognise the value.
Growth at Reasonable Price
Revenue growing 17% with P/E of 14×. Growth isn't fully priced in.
Strong Capital Return
Shareholder yield 5.9% backed by 14.6% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (87%) significantly exceeds 252-day (37%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
82.9% avg (7 factors)
Quality
B
69.5% avg (6 factors)
Momentum
C
59.1% avg (4 factors)
Risk
C
54.5% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.980 | —1 | — | |
| Value %ile | 0.930 | —1 | — | |
| Quality %ile | 0.980 | —1 | — | |
| Momentum %ile | 0.910 | —1 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 0.758 | —1 | — | |
| Volatility | 0.373 | —0 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
13.61
Earnings Yield (E/P)
0.1292
Price / Sales
1.52
Price / Book
2.53
FCF Yield
14.6%
EBITDA / EV
14.5%
Sales Yield (1/P·S)
0.8565
Shareholder Yield
Div + net buyback / mktcap
5.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
18.6%
Return on Assets
12.7%
Net Margin
11.2%
Operating Margin
15.1%
Gross Profit / Assets
Novy-Marx GPA
69.3%
Current Ratio
2.72
MomentumPrice trend strength over different horizons
6M Return
10.8%
12M Return
35.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
27.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.73
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
17.3%
Earnings Growth (YoY)
21.1%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
4.3%
Buyback Yield
1.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
12
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
10
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
11
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
11
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity